Secondary damage in the spinal cord after motor cortex injury in rats.
When neurons within the motor cortex are fatally injured, their axons, many of which project into the spinal cord, undergo wallerian degeneration. Pathological processes occurring downstream of the cortical damage have not been extensively studied. We created a focal forelimb motor cortex injury in rats and found that axons from cell bodies located in the hindlimb motor cortex (spared by the cortical injury) become secondarily damaged in the spinal cord. To assess axonal degeneration in the spinal cord, we quantified silver staining in the corticospinal tract (CST) at 1 week and 4 weeks after the injury. We found a significant increase in silver deposition at the thoracic spinal cord level at 4 weeks compared to 1 week post-injury. At both time points, no degenerating neurons could be found in the hindlimb motor cortex. In a separate experiment, we showed that direct injury of neurons within the hindlimb motor cortex caused marked silver deposition in the thoracic CST at 1 week post-injury, and declined thereafter. Therefore, delayed axonal degeneration in the thoracic spinal cord after a focal forelimb motor cortex injury is indicative of secondary damage at the spinal cord level. Furthermore, immunolabeling of spinal cord sections showed that a local inflammatory response dominated by partially activated Iba-1-positive microglia is mounted in the CST, a viable mechanism to cause the observed secondary degeneration of fibers. In conclusion, we demonstrate that following motor cortex injury, wallerian degeneration of axons in the spinal cord leads to secondary damage, which is likely mediated by inflammatory processes.
Centre for Neuroscience, University of Alberta, Edmonton, Alberta, Canada.
Nina
N
Weishaupt
Gergely
G
Silasi
Frederick
F
Colbourne
Karim
K
Fouad
D000818:Animals; D048588:Benzoxazines; D002135:Calcium-Binding Proteins / Q000096:biosynthesis / Q000235:genetics; D002560:Cerebrovascular Circulation / Q000502:physiology; D004396:Coloring Agents; D004525:Efferent Pathways / Q000293:injuries; D005452:Fluoresceins; D005456:Fluorescent Dyes; D005552:Forelimb / Q000294:innervation; D006614:Hindlimb / Q000294:innervation; D007150:Immunohistochemistry; D008297:Male; D008840:Microfilament Proteins; D017628:Microglia / Q000473:pathology; D009044:Motor Cortex / Q000098:blood supply / Q000293:injuries* / Q000473:pathology*; D009410:Nerve Degeneration / Q000473:pathology; D009412:Nerve Fibers / Q000473:pathology; D009930:Organic Chemicals; D010078:Oxazines; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D016622:Silver Staining; D013116:Spinal Cord / Q000473:pathology*
C100745:Aif1 protein, rat; D048588:Benzoxazines; D002135:Calcium-Binding Proteins; D004396:Coloring Agents; D005452:Fluoresceins; D005456:Fluorescent Dyes; D008840:Microfilament Proteins; D009930:Organic Chemicals; D010078:Oxazines; C435731:fluoro jade; C028911:cresyl violet